BioXcel Therapeutics, Inc. Defined Contribution Plan, Employer Discretionary Contribution Amount
BioXcel Therapeutics, Inc. (BTAI) reported Defined Contribution Plan, Employer Discretionary Contribution Amount of $176.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount · last filed 2026-03-27
- BioXcel Therapeutics, Inc. defined contribution plan, employer discretionary contribution amount for fiscal 2025 was $176.00K, a 39.10% decline from fiscal 2024.
- BioXcel Therapeutics, Inc. defined contribution plan, employer discretionary contribution amount for fiscal 2024 was $289.00K, a 63.32% decline from fiscal 2023.
- BioXcel Therapeutics, Inc. defined contribution plan, employer discretionary contribution amount for fiscal 2023 was $788.00K, a 38.73% increase from fiscal 2022.
- BioXcel Therapeutics, Inc. defined contribution plan, employer discretionary contribution amount for fiscal 2022 was $568.00K.
| Period end | Defined Contribution Plan, Employer Discretionary Contribution Amount 12 month |
|---|---|
| 2025-12-31 | $176.00K 10-K · filed 2026-03-27 |
| 2024-12-31 | $289.00K 10-K · filed 2026-03-27 |
| 2023-12-31 | $788.00K 10-K · filed 2025-03-28 |
| 2022-12-31 | $568.00K 10-K · filed 2024-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |